Abstract
BackgroundBelimumab (Benlysta) is a human monoclonal antibody that inhibits soluble B-Lymphocyte Stimulator and improves SLE disease activity.ObjectivesThis study was initiated to evaluate the use and efficacy of Belimumab in academic...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have